|
1
|
Pascolini D, Mariotti SP, Pokharel GP,
Pararajasegaram R, Etya'ale D, Négrel AD and Resnikoff S: 2002
global update of available data on visual impairment: A compilation
of population-based prevalence studies. Ophthalmic Epidemiol.
11:67–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Congdon N, O'Colmain B, Klaver CC, Klein
R, Muñoz B, Friedman DS, Kempen J, Taylor HR and Mitchell P; Eye
Diseases Prevalence Research Group: Causes and prevalence of visual
impairment among adults in the United States. Arch Ophthalmol.
122:477–485. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
West S: Epidemiology of cataract:
Accomplishments over 25 years and future directions. Ophthalmic
Epidemiol. 14:173–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Resnikoff S, Pascolini D, Etya'ale D,
Kocur I, Pararajasegaram R, Pokharel GP and Mariotti SP: Global
data on visual impairment in the year 2002. Bull World Health
Organ. 82:844–851. 2004.
|
|
5
|
Cruciani F, Amore F, Albanese G and
Anzidei R: Investigation about causes of blindness and low vision
among members of Blind and Visually Impaired Italian Union (UICI).
Clin Ter. 162:e35–e42. 2011.PubMed/NCBI
|
|
6
|
WHO releases the new global estimates on
visual impairment. Accessed on, http://www.who.int/blindness/en/2011.
|
|
7
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peters L and Meister G: Argonaute
proteins: Mediators of RNA silencing. Mol Cell. 26:611–623. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karali M, Peluso I, Marigo V and Banfi S:
Identification and characterization of microRNAs expressed in the
mouse eye. Invest Ophthalmol Vis Sci. 48:509–515. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ryan DG, Oliveira-Fernandes M and Lavker
RM: MicroRNAs of the mammalian eye display distinct and overlapping
tissue specificity. Mol Vis. 12:1175–1184. 2006.PubMed/NCBI
|
|
11
|
Maegdefessel L: The emerging role of
microRNAs in cardiovascular disease. J Intern Med. 276:633–644.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee YH, Kim SY and Bae YS: Upregulation of
miR-760 and miR-186 is associated with replicative senescence in
human lung fibroblast cells. Mol Cells. 37:620–627. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mimura S, Iwama H, Kato K, Nomura K,
Kobayashi M, Yoneyama H, Miyoshi H, Tani J, Morishita A, Himoto T,
et al: Profile of microRNAs associated with aging in rat liver. Int
J Mol Med. 34:1065–1072. 2014.PubMed/NCBI
|
|
14
|
Khee SG, Yusof YA and Makpol S: Expression
of senescence-associated microRNAs and target genes in cellular
aging and modulation by tocotrienol-rich fraction. Oxid Med Cell
Longev. 2014:7259292014.PubMed/NCBI
|
|
15
|
Hughes AE, Bradley DT, Campbell M, Lechner
J, Dash DP, Simpson DA and Willoughby CE: Mutation altering the
miR-184 seed region causes familial keratoconus with cataract. Am J
Hum Genet. 89:628–633. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kota J, Chivukula RR, O'Donnell KA,
Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P,
Torbenson M, Clark KR, et al: Therapeutic microRNA delivery
suppresses tumorigenesis in a murine liver cancer model. Cell.
137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lanford RE, Hildebrandt-Eriksen ES, Petri
A, Persson R, Lindow M, Munk ME, Kauppinen S and Ørum H:
Therapeutic silencing of microRNA-122 in primates with chronic
hepatitis C virus infection. Science. 327:198–201. 2010. View Article : Google Scholar
|
|
18
|
Wang Z, Rajaraman P, Melin BS, Chung CC,
Zhang W, McKean-Cowdin R, Michaud D, Yeager M, Ahlbom A, Albanes D,
et al: Further confirmation of germline glioma risk variant
rs78378222 in TP53 and its implication in tumor tissues via
integrative analysis of TCGA data. Hum Mutat. 36:684–688.
PubMed/NCBI
|
|
19
|
Guan X, Wang LE, Liu Z, Sturgis EM and Wei
Q: Association between a rate novel TP53 variant (rs78378222) and
melanoma, squamous cell carcinoma of the head and neck and lung
cancer susceptibility in non-Hispanic Whites. J Cell Mol Med.
17:873–878. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Long AC, Bomser JA, Grzybowski DM and
Chandler HL: All-trans retinoic acid regulates cx43 expression, gap
junction communication and differentiation in primary lens
epithelial cells. Curr Eye Res. 35:670–679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carlson RV, Boyd KM and Webb DJ: The
revision of the Declaration of Helsinki: Past, present and future.
Br J Clin Pharmacol. 57:695–713. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chylack LT Jr, Wolfe JK, Singer DM, Leske
MC, Bullimore MA, Bailey IL, Friend J, McCarthy D and Wu SY: The
lens opacities classification system III. The longitudinal study of
cataract study group. Arch Ophthalmol. 111:831–836. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferracin M, Bassi C, Pedriali M, Pagotto
S, D'Abundo L, Zagatti B, Corrà F, Musa G, Callegari E, Lupini L,
et al: miR-125b targets erythropoietin and its receptor and their
expression correlates with metastatic potential and ERBB2/HER2
expression. Mol Cancer. 12:1302013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun YM, Lin KY and Chen YQ: Diverse
functions of miR-125 family in different cell contexts. J Hematol
Oncol. 6:62013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bousquet M, Nguyen D, Chen C, Shields L
and Lodish HF: MicroRNA-125b transforms myeloid cell lines by
repressing multiple mRNA. Haematologica. 97:1713–1721. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ge Y, Sun Y and Chen J: IGF-II is
regulated by microRNA-125b in skeletal myogenesis. J Cell Biol.
192:69–81. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bi Q, Tang S, Xia L, Du R, Fan R, Gao L,
Jin J, Liang S, Chen Z, Xu G, et al: Ectopic expression of MiR-125a
inhibits the proliferation and metastasis of hepatocellular
carcinoma by targeting MMP11 and VEGF. PLoS One. 7:e401692012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu N, Zhang L, Meisgen F, Harada M,
Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E and Pivarcsi A:
MicroRNA-125b down-regulates matrix metallopeptidase 13 and
inhibits cutaneous squamous cell carcinoma cell proliferation,
migration, and invasion. J Biol Chem. 287:29899–29908. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thomas DC, Haile RW and Duggan D: Recent
developments in genomewide association scans: A workshop summary
and review. Am J Hum Genet. 77:337–345. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rao AK, Vinothkumar V, Revathidevi S,
Arunkumar G, Manikandan M, Arun K, Rajkumar KS, Ramani R,
Ramamurthy R and Munirajan AK: Abscence of the TP53 poly-A signal
sequence variant rs78378222 in oral, cervical and breast cancers in
South India. Asian Pac J Cancer Prev. 15:9555–9556. 2014.
View Article : Google Scholar
|
|
31
|
Egan KM, Nabors LB, Olson JJ, Monteiro AN,
Browning JE, Madden MH and Thompson RC: Rare TP53 genetic variant
associated with glioma risk and outcome. J Med Genet. 49:420–421.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stacey SN, Sulem P, Jonasdottir A, Masson
G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA,
Sigurgeirsson B, Thorisdottir K, et al: A germline variant in the
TP53 polyadenylation signal confers cancer susceptibility. Nat
Genet. 43:1098–1103. 2011. View
Article : Google Scholar : PubMed/NCBI
|
